glp 1 drugs eli lilly stock soars on encouraging results for daily weight-loss pill Eli Lilly Is More Than
Description
There is a critical need to identify new molecular targets to expand the range of treatment options for AUD
Six percent of US adults are currently on GLP-1s, according to Kaiser research
By potentially dampening inflammatory processes, GLP-1 receptor agonists may help stabilise atherosclerotic plaques, improve endothelial function, and reduce thrombotic risk
Xie X, Yang S, Deng S, Liu Y, Xu Z, He B
